BlackRock’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,482,697
| Closed | -$3.34M | – | 5613 |
|
|
2023
Q2 | $3.34M | Buy |
3,482,697
+34,219
| +1% | +$33.8K | ﹤0.01% | 3864 |
|
|
2023
Q1 | $2.59M | Sell |
3,448,478
-426,229
| -11% | -$311K | ﹤0.01% | 3932 |
|
|
2022
Q4 | $1.43M | Sell |
3,874,707
-3,344,460
| -46% | -$1.41M | ﹤0.01% | 4277 |
|
|
2022
Q3 | $3.1M | Sell |
7,219,167
-659,036
| -8% | -$648K | ﹤0.01% | 3968 |
|
|
2022
Q2 | $6.15M | Sell |
7,878,203
-7,911,020
| -50% | -$6.97M | ﹤0.01% | 3727 |
|
|
2022
Q1 | $20.4M | Sell |
15,789,223
-14,426,724
| -48% | -$13.3M | ﹤0.01% | 3163 |
|
|
2021
Q4 | $38.4M | Sell |
30,215,947
-315,488
| -1% | -$564K | ﹤0.01% | 2842 |
|
|
2021
Q3 | $66.6M | Buy |
30,531,435
+336,548
| +1% | +$920K | ﹤0.01% | 2473 |
|
|
2021
Q2 | $113M | Buy |
30,194,887
+2,021,459
| +7% | +$7.02M | ﹤0.01% | 2175 |
|
|
2021
Q1 | $91.8M | Buy |
28,173,428
+352,449
| +1% | +$1.26M | ﹤0.01% | 2237 |
|
|
2020
Q4 | $94.9M | Buy |
27,820,979
+1,352,785
| +5% | +$5.57M | ﹤0.01% | 2119 |
|
|
2020
Q3 | $108M | Buy |
26,468,194
+7,078,707
| +37% | +$26.9M | ﹤0.01% | 1829 |
|
|
2020
Q2 | $65.5M | Buy |
19,389,487
+1,102,094
| +6% | +$3.21M | ﹤0.01% | 2102 |
|
|
2020
Q1 | $42.6M | Sell |
18,287,393
-547,200
| -3% | -$1.5M | ﹤0.01% | 2151 |
|
|
2019
Q4 | $68.6M | Buy |
18,834,593
+627,538
| +3% | +$5.07M | ﹤0.01% | 2172 |
|
|
2019
Q3 | $151M | Buy |
18,207,055
+668,060
| +4% | +$5.4M | 0.01% | 1630 |
|
|
2019
Q2 | $151M | Buy |
17,538,995
+778,654
| +5% | +$6.96M | 0.01% | 1626 |
|
|
2019
Q1 | $179M | Buy |
16,760,341
+226,089
| +1% | +$2.42M | 0.01% | 1494 |
|
|
2018
Q4 | $145M | Sell |
16,534,252
-1,285,793
| -7% | -$16.4M | 0.01% | 1552 |
|
|
2018
Q3 | $299M | Buy |
17,820,045
+1,292,819
| +8% | +$28M | 0.01% | 1174 |
|
|
2018
Q2 | $346M | Buy |
16,527,226
+1,463,249
| +10% | +$27.1M | 0.02% | 1007 |
|
|
2018
Q1 | $242M | Sell |
15,063,977
-925,953
| -6% | -$18.3M | 0.01% | 1207 |
|
|
2017
Q4 | $303M | Buy |
15,989,930
+4,012,596
| +34% | +$72.7M | 0.01% | 1065 |
|
|
2017
Q3 | $169M | Buy |
11,977,334
+544,344
| +5% | +$4.92M | 0.01% | 1494 |
|
|
2017
Q2 | $85.2M | Sell |
11,432,990
-242,790
| -2% | -$1.59M | ﹤0.01% | 1912 |
|
|
2017
Q1 | $75.9M | Buy |
11,675,780
+11,642,413
| +34,892% | +$65.1M | ﹤0.01% | 1959 |
|
|
2016
Q4 | $148K | Sell |
33,367
-1,097
| -3% | -$4.6K | ﹤0.01% | 2322 |
|
|
2016
Q3 | $161K | Buy |
34,464
+859
| +3% | +$5.09K | ﹤0.01% | 2304 |
|
|
2016
Q2 | $220K | Buy |
33,605
+28,732
| +590% | +$203K | ﹤0.01% | 2043 |
|
|
2016
Q1 | $31K | Buy |
4,873
+2,949
| +153% | +$15.1K | ﹤0.01% | 2630 |
|
|
2015
Q4 | $11K | Sell |
1,924
-2,200
| -53% | -$12.6K | ﹤0.01% | 2867 |
|
|
2015
Q3 | $24K | Buy |
4,124
+2,200
| +114% | +$15.3K | ﹤0.01% | 2291 |
|
|
2015
Q2 | $14K | Hold |
1,924
| – | – | ﹤0.01% | 2601 |
|
|
2015
Q1 | $11K | Hold |
1,924
| – | – | ﹤0.01% | 2698 |
|
|
2014
Q4 | $14K | Hold |
1,924
| – | – | ﹤0.01% | 2566 |
|
|
2014
Q3 | $16K | Hold |
1,924
| – | – | ﹤0.01% | 2462 |
|
|
2014
Q2 | $16K | Hold |
1,924
| – | – | ﹤0.01% | 2511 |
|
|
2014
Q1 | $15K | Hold |
1,924
| – | – | ﹤0.01% | 2513 |
|
|
2013
Q4 | $17K | Hold |
1,924
| – | – | ﹤0.01% | 2451 |
|
|
2013
Q3 | $16K | Hold |
1,924
| – | – | ﹤0.01% | 2387 |
|
|
2013
Q2 | $15K | Buy |
+1,924
| New | +$14.8K | ﹤0.01% | 2449 |
|
BlackRock's SPPI Position: Q3 2023 in Review
BlackRock sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 3,482,697 shares — an estimated $3.34M sold.
BlackRock first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $346M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- BlackRock reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- BlackRock sold 3,482,697 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $3.34M.
- BlackRock first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
- BlackRock's Spectrum Pharmaceuticals Inc position peaked at $346M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.